Increased mortality associated with the metabolic syndrome in older women with diabetes

Diabetes Care

Volumn 28, Issue 9, 2005, Pages 2258-2260

  Hillier, Teresa A ^a   Rizzo, Joanne H ^a   Pedula, Kathryn L ^a   Cauley, Jane A ^b   Schwartz, Ann V ^c   Ensrud, Kristine E ^d,e   Browner, Warren S ^f  

^a CENTER FOR HEALTH RESEARCH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; TRIACYLGLYCEROL;

AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; EPIDEMIOLOGICAL DATA; FEMALE; FOLLOW UP; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; MORTALITY; OSTEOPOROSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; UNITED STATES; WORLD HEALTH ORGANIZATION;

AGED; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; METABOLIC SYNDROME X; OBESITY; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 24144438263     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.9.2258     Document Type: Article

References (22)

1. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287:356-359, 2002
2. Brewer HB Jr: Rising to the challenge of the new NCEP ATP III guidelines: exceeding current therapeutic limitations. Am J Manag Care 8:S23-S28, 2002
3. Gorman C: Why so many of us are getting diabetes. Time 162:59-69, 2003
4. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288:2709-2716, 2002
5. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24:683-689, 2001
6. Ford ES: The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 173: 307-312, 2004
7. Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP: National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 110:1251-1257, 2004
8. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, Williams GR: Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110: 1245-1250, 2004
9. Girman CJ, Rhodes T, Mercuri M, Pyorala K, Kjekshus J, Pedersen TR, Beere PA, Gotto AM, Clearfield M: The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol 93:136-141, 2004
10. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K: Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 164:1066-1076, 2004
11. Anderson RN, Smith BL: Deaths: leading causes for 2001. Natl Vital Stat Rep 52:1-85, 2003
12. Hillier TA, Pedula KL: Complications in young adults with early-onset type 2 diabetes: losing the relative protection of youth. Diabetes Care 26:2999-3005, 2003
13. Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM: Risk factors for hip fracture in white women: study of Osteoporotic Fractures Research Group. N Engl J Med 332:767-773, 1995
14. Lohman TG, Roche AF, Mortorell R: Anthropometric Standardization Reference Manual. Champaign, IL, Human Kinetics Books, 1988, p. 177
15. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC: Enzymatic determination of total serum cholesterol. Clin Chem 20: 470-475, 1974
16. Bucolo G, David H: Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 19:476-482, 1973
17. Warnick GR, Albers JJ: A comprehensive evaluation of the heparin manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res 29:65-76, 1987
18. World Health Organization: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. In Report of a WHO Consultation. Geneva, World Health Organization, 1999
19. Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults: Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285: 2486-2497, 2001
20. Balkau B, Charles MA: Comment on the provisional report from the WHO consultation: European Group for the Study of Insulin Resistance (EGIR). Diabet Med 16: 442-443, 1999
21. American Heart Association: 2002 Heart and Stroke Statistical Update, [article online], 2003. Available from http://www. americanheart.org/statistics/ biostats/biowo. htm. Accessed 21 February 2005
22. Bruno G, Merletti F, Biggeri A, Bargero G, Ferrero S, Runzo C, Prina Cerai S, Pagano G, Cavallo-Perin P: Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. Diabetes Care 27:2689-2694, 2004